|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Policy: Task Masters
Author(s)Kevin Gopal
London-Government and industry have agreed there should be no weakening of patent protection in the effort to speed access to medicines in the developing world.
Advertisement
Articles in this issue
over 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearover 25 years ago
Friends of Complexityover 25 years ago
Under Federal Fireover 25 years ago
Task Force: Enter the Fixersover 25 years ago
The Next Y2Kover 25 years ago
Political ScienceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5